#hemab-therapeutics
Latest news and interesting information about hemab-therapeutics.
Goldman Sachs Initiates Hemab Buy
Goldman Sachs initiates Hemab Therapeutics with buy rating. Sutacimig and HMB-002 target rare bleeding disorders.
...
Latest news and interesting information about hemab-therapeutics.